Cancer discovery news
Our researchers are making the discoveries that defeat cancer. Read the latest findings from our world-leading research.
Visit our main news hub to read about news on new funding, our fundraising activities and much more. If you want to keep updated on our news, you can follow us on social media or sign up for our Search newsletter.
If you’re a journalist and want to find out more, you can contact our media relations team.
‘Master switch’ helps cancer cells survive stress
New survival mechanism could be a target for future cancer drugs
Carols by Candlelight
The stunning Wren Chapel of The Royal Hospital Chelsea was the setting for Carols from Chelsea – The Institute of Cancer Research’s flagship annual social and fundraising event.
New computational test predicts ovarian cancer survival
Scientists have developed a new automated way of predicting the survival chances from ovarian cancer from routine biopsy samples, by looking at the cells in the environment around tumours.
ICR donors celebrate a year of scientific discovery
Members of The Institute of Cancer Research, London’s Discovery Club gathered at the 4th Annual Reception to celebrate the scientific achievements made possible over the past year thanks to philanthropic investment from donors and supporters.
New drug combination treats kidney cancers
New research shows that a combination of two existing drug types slows the growth of kidney cancer by suppressing the development of new tumour blood vessels more effectively than existing treatments.
The Climb of Life beats £100,000 target
The ICR's annual Climb of Life fundraising event has raised a fantastic £101,260, surpassing last year’s final total and raising more than £650,000 in a decade.
Ecological technique to find cancer-tracking immune cells predicts breast cancer survival
A system used by ecologists to study predator-prey interactions could predict breast cancer survival, according to ICR research.
ICR video celebrates Mel Greaves’ Lifetime Achievement Award
Professor Mel Greaves discusses his 30 years at the ICR in a video about the science which recently won him Cancer Research UK’s Lifetime Achievement award.
Statement about plans to reform Cancer Drugs Fund
ICR CEO Professor Paul Workman comments on new plans to reform the Cancer Drugs Fund in England.
MRI could detect head and neck cancer’s resistant cores
Grouping magnetic resonance imaging data into clusters could detect treatment-resistant cores inside head and neck tumours, a new study shows.
Using radiotracers to spy on cancer’s secrets
Scientists are developing new imaging techniques that track cancer’s metabolism using radiolabelled amino acids
Blood test detects when hormone treatment for breast cancer stops working
Scientists have developed a highly sensitive blood test that can spot when breast cancers become resistant to standard hormone treatment, and have demonstrated that this test could guide further treatment.